Search

everythinglearnresearchcommunity

for

Search:↓

Acne is an important sign of androgen excess disorders in women.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

Finasteride side effects in young men may be linked to specific gene variations.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

Longer GGN repeats in the androgen receptor gene are linked to polycystic ovary syndrome.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Certain gene variations are linked to better memory in healthy Chinese women.

Certain gene variations might be linked to severe acne in women but not in men.

The length of CAG repeats in the androgen receptor gene is linked to ovarian reserve but does not affect how the ovaries respond to stimulation.

Testosterone is crucial for development, growth, and various body functions in mammals.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Anti-androgens are effective for female acne but less so for male-pattern hair loss, with side effects similar to birth control pills.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

The mouse models are effective for testing new hair loss treatments.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Dihydrotestosterone (DHT) is crucial for conditions like male-pattern baldness and acne, and measuring a byproduct, androstanediol glucuronide, is a better way to assess DHT's effects than DHT blood levels.

Androgens like testosterone affect hair growth and oil production differently across body parts and individuals.

High aldosterone and free testosterone levels link to female hair loss; testing aldosterone may predict hypertension risk.

Insufficient androgen action in male fetuses can cause genital development issues due to genetic mutations or environmental chemicals.

The mouse model suggests male pattern baldness may be due to an enzyme increasing DHT and higher androgen receptor levels in hair follicles.

Certain gene variations are linked to severe acne in Egyptian patients and could guide treatment choices.

Androgen receptors are active in many tissues of both male and female mice, not just reproductive organs.

Hormonal treatments can help with acne, especially in women, by lowering androgen levels or blocking their effects.

Finasteride reduces hairiness and androgen levels in women with unexplained excessive hair growth.